PT  - JOURNAL ARTICLE
AU  - Elliott D Crouser
AU  - Emily Ruden
AU  - Mark W Julian
AU  - Subha V Raman
TI  - Resolution of abnormal cardiac MRI T2 signal following immune suppression for cardiac sarcoidosis
AID  - 10.1136/jim-2016-000144
DP  - 2016 Aug 01
TA  - Journal of Investigative Medicine
PG  - 1148--1150
VI  - 64
IP  - 6
4099  - http://hw-f5-jim.highwire.org/content/64/6/1148.short
4100  - http://hw-f5-jim.highwire.org/content/64/6/1148.full
SO  - J Investig Med2016 Aug 01; 64
AB  - Cardiac MR (CMR) with late gadolinium enhancement is commonly used to detect cardiac damage in the setting of cardiac sarcoidosis. The addition of T2 mapping to CMR was recently shown to enhance cardiac sarcoidosis detection and correlates with increased cardiac arrhythmia risk. This study was conducted to determine if CMR T2 abnormalities and related arrhythmias are reversible following immune suppression therapy. A retrospective study of subjects with cardiac sarcoidosis with abnormal T2 signal on baseline CMR and a follow-up CMR study at least 4 months later was conducted at The Ohio State University from 2011 to 2015. Immune suppression treated participants had a significant reduction in peak myocardial T2 value (70.0±5.5 vs 59.2±6.1 ms, pretreatment vs post-treatment; p=0.017), and 83% of immune suppression treated subjects had objective improvement in cardiac arrhythmias. Two subjects who had received inadequate immune suppression treatment experienced progression of cardiac sarcoidosis. This report indicates that abnormal CMR T2 signal represents an acute inflammatory manifestation of cardiac sarcoidosis that is potentially reversible with adequate immune suppression therapy.